Gordillo-Pérez G, Torres J, Solórzano-Santos F, Garduño-Bautista V, Tapia-Conyer R, Muñoz O

Language: Spanish
References: 17
Page: 351-355
PDF size: 122.91 Kb.

ABSTRACT

Objective. To detect serological evidence of B burgdorferi infection in individuals from Mexico City and from the Northeast Region of the country. Material and Methods. A representative sample size of serum from Mexico City and the states of the Northeast of Mexico were taken from serum samples corresponding to the 1987-1988 national survey were obtained from the National Serum Bank. Antibodies against B burgdorferi were detected by ELISA and confirmed with Western blot (WB) assays. Data were analyzed using descriptive statistics. Results. A total of 2 346 serum samples were tested; 297 (12.6%) were positive for ELISA, and 122 of 297 were confirmed by WB. Seroprevalence was 3.43% in Mexico City and 6.2% in the Northeast region of the country. Tamaulipas was the state with the highest seroprevalence. Conclusions. The prevalence of seropositive cases shows that borrelial infection is present in the northeast of Mexico and Mexico City. Identification of clinical cases and infected tick vectors is necessary to confirm the presence of Lyme disease in Mexico.

REFERENCES

1. Steere AC. Lyme disease. N Engl J Med 1989;321:586-595.

2. Fahrer H,Van der LSM, Sauvain Ml, Gern L, Zhioua E, Aeschliman A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk.) Infect Dis 1991;163:305-310.

3. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population.) Infect Dis 1986;154:295-300.

4. Guzmán L, Neira O. Lyme disease in Chile. J Rheumatol 1993;20: 774-775.

5. Hoffmann A. Monografía de los Ixodoidea de México. Rev Soc Mex Hist Nat 1962;XXIII:197-282.

6. Maradiaga-Ceceña MA, Llausás-Vargas A, Barguera-Heredia J, Kumate-Rodriguez J. Eritema crónico migratorio asociado a artritis. Enfermedad de Lyme o una variante. Rev Mex Reumatol 1991;6:61.

7. Arroyave MC,Támez GR. Enfermedad de Lyme, informe de dos casos. Bol Med Hosp Infant Mex 1994;51:117-121.

8. Gordillo G,Torres J, Solórzano F, Cedillo RR,Tapia CR, Muñoz O. Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico.Arch Med Res 1999;30:64-68.

9. Tapia CR, Gutiérrez G, Sepúlveda J. Metodología de la Encuesta Nacional Seroepidemiológica, México. Salud Publica Mex 1992;34: 124-135.

10. Russell H, Sampson JS, Schmid GP,Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.) Infec Dis 1984;149:465-470.

11. Dressler F, Whalen JA, Remhardt BN, Steere AC.Western blotting in the serodiagnosis of Lyme disease.) Infec Dis 1993;167:392-400.

12. Centers for Disease Control and Prevention. Recomendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. Morbid Mortal Wkly Rep 1995;44:590.

13. Norman GL, Antig JM, Bigaignon G, Hogrefe WR. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii y B. afzelii western blots (immunoblots).J Clin Microbio! 1996;34:1732-1738.

14. Hauser U, Lehnert G,Wilske B.Validity of interpretation criteria for standarized western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.) Clin Microbiol 1999;37:2241-2247.

15. Tilton RC, Sand MR, Manak M.The western immunoblot for Lyme disease. Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels. Clin Infect Dis 1997;25(Suppl 1):S31 -S34.

16. Martínez A, Salinas A, Martínez F, Canté A, Miller DK. Serosurvey for selected disease agents in white-tailed deer from Mexico. J Wildlife Dis 1999;35(4):799- 803.

17. Gordillo-Pérez MG, Estrada-Correa G, Solórzano-Santos F, Torres-López ), Muñoz HO. Evidencias serológicas y moleculares de neuroborreliosis de Lyme en México. XXIII Reunión Anual de la Academia de Neurología; 1999 oct 30-nov 2; Los Cabos, Baja California Sur, México.